Covishield is set to “roll out in the next few weeks,” Adar Poonawalla said. (File photo) New Delhi: All the risks taken by the Serum Institute have finally paid off, tweeted Adar Poonawalla, CEO of the Pune-based vaccine manufacturer, shortly after the country’s drug regulator authorized its Covishield vaccine for …
Read More »‘It was finally worth it’: Adar Poonawalla thanks Prime Minister Modi, DCGI after Covishield gets final approval
For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …
Read More »Electoral process-based vaccination campaign, says Harsh Vardhan; Regulator likely to specify dosage details today
The other vaccine, known as COVAXIN, has been developed locally by Bharat Biotech and the government-run Indian Council for Medical Research. Reuters, citing sources, reported on Friday that the injection could be approved, although little is known about the results of its clinical trials. “Granting permission for restricted use in …
Read More »Efficacy of Oxford Bumps 95% when given 3 months apart: IBS
AstraZeneca Plc will soon publish data showing that the effectiveness of its covid-19 vaccine increases up to 95% if the two injections are separated by approximately 2-3 months, said Adar Poonawalla, executive director of the Serum Institute of India (SII), partner. manufacturing company British. “You will be getting good news …
Read More »Most of Oxford’s Top 50 Million Injections for India – Director of the Serum Institute
Coronavirus: Adar Poonawalla Says Serum Institute Will Give First 50 Million Doses Of Covishield To India New Delhi: Stating that the delay in approval of the COVID-19 Oxford-AstraZeneca vaccine, produced en masse by his company, was not concerning, Adar Poonawalla from the Serum Institute of India (SII) said the inoculant …
Read More »Waiting for the approval of the Oxford Covid vaccine soon; 50 million doses ready: CEO of the Serum Institute | India News
NEW DELHI: The Serum Institute of India said on Monday it has already produced nearly 50 million doses of the Oxford-AstraZeneca Covid-19 vaccine and awaits emergency use approval from Indian and UK regulators in the ” next days”. “You will hear good news from the UK very soon,” Serum CEO …
Read More »Kareena Kapoor Khan, Malaika Arora, Ayushmann Khurrana: Inside B-town’s Christmas celebrations with their families: fashion and trends
After the year everyone has had because of the coronavirus pandemic, we are all definitely looking for any excuse to celebrate and find positivity in this new normal. Christmas and the New Year are usually a time to give, share, celebrate, celebrate, and express gratitude, and while curfews and restrictions …
Read More »Government must indemnify vaccine manufacturers against all lawsuits: Adar Poonawalla | India News
NEW DELHI: Vaccine manufacturers must have protection against all lawsuits by vaccinations especially during a pandemic, the executive director of the Serum Institute of India (SII) Adar Poonawalla has said. He also said that vaccine makers will propose this to the government, while speaking on a virtual panel about the …
Read More »Government Must Protect Vaccine Manufacturers Against Lawsuits, Frivolous Claims Invite Skepticism: Adar Poonawalla
Vaccine manufacturers must have protection against all lawsuits for their vaccines, especially during a pandemic, said Serum Institute of India (SII) executive director Adar Poonawalla. He also said that vaccine manufacturers are going to propose this to the government, while speaking on a virtual panel about the challenges of developing …
Read More »Government Must Protect Vaccine Manufacturers Against Lawsuits: Adar Poonawalla From IBS
Manufacturers of vaccines against coronavirus disease (Covid-19) should be protected from liability in the event of serious adverse reactions or other claims to their vaccines during a pandemic, said the executive director of the Serum Institute of India (SII). ), Adar Poonawalla. Poonawalla, who made the remarks during a virtual …
Read More »